Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for nanotechnology industry professionals · Wednesday, April 24, 2024 · 706,032,066 Articles · 3+ Million Readers

Drug Discovery Technologies Market 2018 Global Analysis, Opportunities and Forecast To 2023

Drug Discovery Technologies -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022

PUNE, MAHARASHTRA, INDIA, February 8, 2018 /EINPresswire.com/ -- Drug Discovery Technologies Industry

Description

Wiseguyreports.Com Adds “Drug Discovery Technologies -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database

According to Stratistics MRC, the Global Drug Discovery Technologies market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. Rise in new diseases and growing demand for therapeutics in various diseases are the factors driving the market growth. Stringent regulations and high initial cost associated with drug discovery are the factors hampering the market. Discovering drugs for diseases like Parkinson disease, cancer, nervous disorders is the opportunity for the market growth.

Some of the key players in the market include

Bayer Healthcare AG, Roche Holding AG, Boehringer Ingelheim GmbH, Illumina Inc., Millennium Pharmaceuticals, Inc., Abbott Laboratories, Beckman Coulter Inc., Aviva Biosciences Corp., Bio-Rad Laboratories, Inc., Novartis AG, Charles River Laboratories International, Inc., Evotec AG, Merck & Co., Inc., Viva Biotech Ltd, Sri Biosciences, GE Healthcare Ltd., Qiagen N.V. and Quantum Pharmaceuticals.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/731667-drug-discovery-technologies-global-market-outlook-2016-2022

Technologies Covered:

• DNA & Protein Microarrays
• High Throughput Screening
• Genomics
• Biochips
• Proteomic Technologies
• Microfluidics
• Metabolomics
• Pharmacogenomics
• Gel Electrophoresis
• Bioanalytical Instruments
• Chromatography
• Bioinformatics
• QPCR
• Combinatorial Chemistry
• Mass Spectrometry
• Nanotechnology
• RNAi
• Nucleic Acid Isolation
• Protein
• Epigenetics
• Cell Based Assays
• Laboratory Information Management Systems

Applications Covered:
• Parkinson’s disease
• Cancer
• Central Nervous System Disorders
• Cardiovascular Diseases
• Other Applications

Leave a Query @ https://www.wiseguyreports.com/enquiry/731667-drug-discovery-technologies-global-market-outlook-2016-2022

End Users Covered:
• Biopharmaceutical Companies
• Research Institutes
• Biotech Companies
• Pharmaceutical Companies

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=731667

Continued...

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release